All Posts: Georgetown Lombardi
-
Determining How a Sugar Molecule Can Affect Cancer Cell Response to Chemoradiotherapy
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues who have been exploring the complexities of biochemical pathways involved in cancer development have found that a form of glucose, a type of sugar, is intricately linked to a pathway used to build DNA molecules. When this pathway is overactive, it can lead to cancer and resistance to chemoradiotherapy.
Category: News Release
-
Types of Bacteria Vary Widely in Tumors of People with Early vs. Late-Onset Colorectal Cancer
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center studied the microbiome of people with colorectal cancer and found the makeup of the bacteria, fungi and viruses in a person’s tumor varied significantly depending on whether they were diagnosed with early onset disease (age 45 or younger) or late-onset disease (age 65 or older). These results may help answer the riddle of why more young people are developing colorectal cancer, particularly those who have no known identifiable risk factors for the disease.
Category: News Release
-
Lombardi Gala Celebrates Hope
Friends and supporters gathered for the 35th annual Lombardi Gala to celebrate life and hope in the face of cancer and rally support for funding cancer research at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: GUMC Stories
-
Georgetown Announces New Ralph Lauren Center for Cancer Prevention To Address Health Disparities in Washington, D.C.
Lombardi Comprehensive Cancer Center’s newly dedicated Ralph Lauren Center for Cancer Prevention brings renewed hope that those who have been historically underserved in the Washington, DC, area will now have access to more cancer-related services, potentially turning the tide on the high rate of cancer in the city.
Category: GUMC Stories
-
Study Finds Relationship Between Discrimination and Frailty in Black Cancer Survivors
Discrimination experienced by Black people can affect their health and increase their frailty, which can be particularly impactful for cancer survivors, according to a new study by researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and others.
Category: News Release
-
Key Studies Conducted at Georgetown Lombardi Lead to Better Treatment for People With Melanoma
Results from a pair of clinical trials published in recent months have changed the treatment landscape for people with advanced melanoma, offering a clearer path for improved survival.
Category: GUMC Stories
-
Ruesch Symposium Participants Encourage Patients to Consider Clinical Trials
Held by the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center, the Ruesch Symposium brings together researchers, clinicians, patients, caregivers, policymakers and advocates for networking and discussion on the latest developments in GI cancer research and treatment.
Category: GUMC Stories
-
Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs
While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce the risk of developing new breast cancers, a new computer modeling study led by researchers at Georgetown Lombardi Comprehensive Cancer Center and colleagues showed that these treatments could also reduce the risk of dying from the disease in women who are at high risk.
Category: News Release
-
Study in Mice Suggests that Expression of Estrogen-Related Gene Can Impact Postmenopausal Breast Cancer Risk and Prevention Strategies
In a study using a first-of-its-kind mouse model of aging that mimics breast cancer development in estrogen receptor-positive postmenopausal women, investigators at Georgetown Lombardi Comprehensive Cancer Center and colleagues have determined that over-expression, or switching on, of the Esr1 gene could lead to elevated risk of developing estrogen receptor-positive breast cancer in older women.
Category: News Release
-
Inaugural BellRinger Ride Raises More Than $1 Million for Cancer Research at Georgetown Lombardi
Category: GUMC Stories